VR and Script Training of PWA
Utilization of Immersive Virtual Reality in Computerized Script Training for People with Aphasia: a Feasibility Study
1 other identifier
interventional
26
1 country
1
Brief Summary
The goal of this intervention study is to investigate the effects of immersive virtual reality in rehabilitation of language and communication of individuals with post-stroke aphasia. The main research questions are:
- 1.Is VR-based script training a feasible treatment to Cantonese-speaking PWA?
- 2.Will VR-based script training, when compared to conventional script training, better enhance treatment outcomes in functional communication of PWA?
- 3.Accuracy and time for producing trained scripts.
- 4.Accuracy and time for producing un-trained scripts
- 5.Standardized aphasia test on severity of language impairment
- 6.Standardized aphasia test on functional communication
- 7.Virtual reality-based computerized script training; or
- 8.Computerized script training without virtual reality Researchers will compare the treatment outcomes of the two treatment conditions and see if treatment with virtual reality would better promote outcomes when compared to training without virtual reality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2022
CompletedFirst Posted
Study publicly available on registry
December 28, 2022
CompletedStudy Start
First participant enrolled
April 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMarch 13, 2025
August 1, 2024
1.7 years
December 11, 2022
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Percentage correct in reading aloud the sentences included in the trained scripts
Trained scripts will be shown in written form while the PWA will be asked to read aloud the scripts.
From baseline up to 1-week post training
Time required in read aloud of trained scripts
Total time to read aloud the trained scripts
From baseline up to 1-week post training
Percentage correct in spontaneous production of the sentences included in the trained scripts
No written cue will be provided while the PWA will produce the scripts upon questions.
From baseline up to 1-week post training
Time required for spantaneous production of trained scripts
No written cue will be provided while the PWA will produce the scripts upon questions.
From baseline up to 1-week post training
Secondary Outcomes (3)
CAB
From baseline up to 1-week post training
CANELT
From baseline up to 1-week post training
Percentage correct in producing untrained but related scripts
From baseline up to 1-week post training
Study Arms (2)
VR-based script training
EXPERIMENTALConventional script training
ACTIVE COMPARATORInterventions
The PWA will wear a head-mounted VR device (e.g., Metaverse Oculus Quest 2 or other commercially available devices) for 30 minutes, which intends to create an immersive environment for training. Scripts trained in the computerized script training program in a particular session will be practiced. Cinematic 360˚ photo-real scenarios of daily contexts such as a restaurant or a grocery store will be displayed in the device while a communication partner, e.g., a waiter in the restaurant or a shopkeeper of a grocery store will initiate the conversation by producing the corresponding part of the script. The PWA will be given time to respond. Upon the completion of PWA's respond, the next conversational turn will be initiated. The clinical assistant, who accompanies the PWA in the entire training session, will control the flow of the 360 ˚ videos.
The flow of training is identical to the VR condition, except that photos depicting the scenarios and pre-recorded conversational turns will be presented to the PWA on a computer screen with the same procedures mentioned in the VR condition.
Eligibility Criteria
You may qualify if:
- a stroke onset more than six months, with an Aphasia Quotient (AQ) below 96.4, as evaluated by the Cantonese version of Western Aphasia Battery (CAB; Yiu, 1992),
- premorbid fluent Cantonese speakers,
- aged between 30 and 80 years,
- no reported progressive neurogenic disorders such as dementia or Parkinson's disease,
- no motor speech disorders of moderate to severe level, and
- normal or corrected-to-normal vision and hearing functions
You may not qualify if:
- concurrent participation in other aphasia treatment trials, and
- incompatibility with immersive VR exposure such as complains of nausea, headache, or other severe discomforts during trial use of a head-mounted device during screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hong Kong Polytechnic University
Hong Kong, Hong Kong SAR, 852, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Winsy WS Wong, PhD
The Hong Kong Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2022
First Posted
December 28, 2022
Study Start
April 10, 2023
Primary Completion
December 31, 2024
Study Completion
June 30, 2025
Last Updated
March 13, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data will be shared starting from three months after manuscript publication.
- Access Criteria
- The IPD and study protocol will be shared in an open-access data repository without restrictions.
The IPD, together with the study protocol, will be shared in an open-access data repository (e.g., Harvard Dataverse).